Ohcanbohtosat - Denis Moro‐Sibilot

Aiddostahte ozu
  1. 1
    First- and second-line therapy for advanced nonsmall cell lung cancer

    First- and second-line therapy for advanced nonsmall cell lung cancer Dahkki Sculier Jp, Denis Moro‐Sibilot

    Almmustuhtton 2009
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib

    Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib Dahkki Oana Lelia Pop, Augustin Pirvu, Anne‐Claire Toffart, Denis Moro‐Sibilot

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer

    Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer Dahkki Denis Moro‐Sibilot, Axel Aubert, Sami Diab, Sylvie Lantuéjoul, P. Fourneret, E. Brambilla, Christian Brambilla, Pierre-Yves Brichon

    Almmustuhtton 2005
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer

    Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer Dahkki Arnaud Van Den Broeck, Élisabeth Brambilla, Denis Moro‐Sibilot, Sylvie Lantuéjoul, Christian Brambilla, Béatrice Eymin, Saadi Khochbin, Sylvie Gazzéri

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Early detection of lung cancer: role of biomarkers

    Early detection of lung cancer: role of biomarkers Dahkki Christian Brambilla, Frédéric Fievet, M. Jeanmart, Florence de Fraipont, Sylvie Lantuéjoul, V. Frappat, G. Ferretti, Pierre-Yves Brichon, Denis Moro‐Sibilot

    Almmustuhtton 2003
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis

    Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis Dahkki Denis Moro‐Sibilot, Sylvie Lantuéjoul, Sami Diab, Nabila Moulaï, Axel Aubert, J. F. Timsit, Christian Brambilla, Pierre-Yves Brichon, E. Brambilla

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study

    Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study Dahkki Anne McLeer‐Florin, Denis Moro‐Sibilot, A. Melis, Dimitri Salameire, Christine Lefebvre, Françoise Ceccaldi, Florence de Fraipont, Élisabeth Brambilla, Sylvie Lantuéjoul

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours

    Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours Dahkki Sylvie Lantuéjoul, Jean‐Charles Soria, Denis Moro‐Sibilot, Luc Morat, Sylvie Veyrenc, P. Lorimier, Pierre-Yves Brichon, Laure Sabatier, Christian Brambilla, Élisabeth Brambilla

    Almmustuhtton 2004
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype

    IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype Dahkki J. Cadranel, Élisabeth Quoix, Laurence Baudrin, Pierre Mourlanette, Denis Moro‐Sibilot, Jean‐François Morère, Pierre-Jean Souquet, Jean‐Charles Soria, Franck Morin, B. Milleron

    Almmustuhtton 2009
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Circulating free DNA concentration is an independent prognostic biomarker in lung cancer

    Circulating free DNA concentration is an independent prognostic biomarker in lung cancer Dahkki Claire Tissot, Anne‐Claire Toffart, Stéphanie Villar, Pierre-Jean Souquet, P. Merle, Denis Moro‐Sibilot, M. Pérol, Jiří Zavadil, Christian Brambilla, Magali Olivier, S. Couraud

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Prognostic Impact of Paraneoplastic Cushing’s Syndrome in Small-Cell Lung Cancer

    Prognostic Impact of Paraneoplastic Cushing’s Syndrome in Small-Cell Lung Cancer Dahkki Hélène Nagy-Mignotte, Oxana Shestaeva, Lucile Vignoud, Pascale Guillem, Stéphane Ruckly, Olivier Chabre, L. Sakhri, M. Duruisseaux, Mireille Mousseau, Jean‐François Timsit, Denis Moro‐Sibilot

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    <i>MET</i> exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung

    <i>MET</i> exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung Dahkki Raphaël Saffroy, Vincent Fallet, Nicolas Girard, Julien Mazières, Denis Moro‐Sibilot, Sylvie Lantuéjoul, Isabelle Rouquette, Françoise Thivolet-Béjui, Thibaut Vieira, Martine Antoine, Jacques Cadranel, Antoinette Lemoine, Marie Wislez

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas

    On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas Dahkki Lénaïg Mescam-Mancini, Sylvie Lantuéjoul, Denis Moro‐Sibilot, Isabelle Rouquette, Pierre-Jean Souquet, Clarisse Audigier-Valette, Jean‐Christophe Sabourin, C. Decroisette, L. Sakhri, Élisabeth Brambilla, Anne McLeer‐Florin

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

    CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients Dahkki J-L. Pujol, Olivier Molinier, W. Ébert, Daurès Jp, Fabrice Barlési, G Buccheri, M Paesmans, Élisabeth Quoix, Denis Moro‐Sibilot, M Szturmowicz, J-M Bréchot, T. Muley, Jean‐Christophe Grenier

    Almmustuhtton 2004
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity

    Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity Dahkki Christian Brambilla, Julien Laffaire, Sylvie Lantuéjoul, Denis Moro‐Sibilot, Hélène Mignotte, François Arbib, Anne‐Claire Toffart, Fabien Petel, Pierre Hainaut, Sophie Rousseaux, Saadi Khochbin, Aurélien de Reyniès, Élisabeth Brambilla

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus

    Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus Dahkki Federico Cappuzzo, Denis Moro‐Sibilot, Oliver Gautschi, Ekaterini Boleti, Enriqueta Felip, Harry J.M. Groen, Paul Germonpré, Peter Meldgaard, Edurne Arriola, N. Steele, J. Fox, Patrick Schnell, Arne Engelsberg, Jürgen Wolf

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Osteoblastic Reaction in Non-small Cell Lung Carcinoma and its Association to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Response and Prolonged Survival

    Osteoblastic Reaction in Non-small Cell Lung Carcinoma and its Association to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Response and Prolonged Survival Dahkki E. Pluquet, J. Cadranel, Anne Legendre, Michelle Beau Faller, Pierre Jean Souquet, Gérard Zalcman, M. Pérol, G. Fraboulet, Gerard Oliveiro, Florence de Fraipont, Élisabeth Quoix, Sylvie Lantuéjoul, B. Milleron, Denis Moro‐Sibilot

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets

    High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets Dahkki Vincent Fallet, Raphaël Saffroy, Nicolas Girard, Julien Mazières, Sylvie Lantuéjoul, T. Vieira, Isabelle Rouquette, F. Thivolet-Béjui, Mony Ung, Virginie Poulot, L. Schlick, Denis Moro‐Sibilot, Martine Antoine, Jacques Cadranel, Antoinette Lemoine, Marie Wislez

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics

    A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics Dahkki Léonie Ferrer, Matteo Giaj Levra, Marie Brevet, Martine Antoine, Julien Mazières, Giulio Rossi, Rita Chiari, Virginie Westeel, M. Poudenx, J. Letreut, Radj Gervais, Giorgia Osman, Nicolas Girard, Anne Claire Toffart, Silvia Novello, Denis Moro‐Sibilot

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations Between Primary Tumor and Metastases From Patients With Non–Small-Cell Lung Cancer

    Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations Between Primary Tumor and Metastases From Patients With Non–Small-Cell Lung Cancer Dahkki Stéphane Vignot, Garrett M. Frampton, Jean‐Charles Soria, Roman Yelensky, Frédéric Commo, Christian Brambilla, Gary A. Palmer, Denis Moro‐Sibilot, Jeffrey S. Ross, Maureen Cronin, Fabrice André, Philip J. Stephens, Vladimir Lazar, Vincent A. Miller, Élisabeth Brambilla

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: